|
Treat to target in systemic lupus erythematosus: a commentary
|
Escrito por Manuel F. Ugarte-Gil |
Visitas: 584
|
|
Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients
|
Escrito por Manuel F. Ugarte-Gil |
Visitas: 578
|
|
Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus
|
Escrito por Manuel F. Ugarte-Gil |
Visitas: 578
|
|
El DAS28VSG correlaciona bien con sus variantes para evaluar la activdad de enfermedad en pacientes con artritis reumatoide
|
Escrito por José Alfaro-Lozano |
Visitas: 532
|
|
Comparison of an Interferon-? Assay with Tuberculin Skin Testing for Detection of Tuberculosis (TB) Infection in Patients with Rheumatoid Arthritis in a TB-Endemic Population
|
Escrito por DARÍO PONCE de LEÓN |
Visitas: 513
|
|
Abatacept for the treatment of systemic lupus erythematosus
|
Escrito por Victor R. Pimentel-Quiroz |
Visitas: 510
|
|
Perspectivas en el Estudio del Fenómeno de Raynaud desde un Punto de Vista Ecográfco
|
Escrito por Oscar L. Sedano |
Visitas: 500
|
|
Access to an optimal treatment. Current situation
|
Escrito por Manuel F. Ugarte-Gil |
Visitas: 491
|
|
Circulating CD4þCD28null and extra-thymic CD4þCD8þ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients
|
Escrito por Manuel F. Ugarte-Gil |
Visitas: 461
|
|
Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo
|
Escrito por Manuel F. Ugarte-Gil |
Visitas: 422
|
